Evidence map›Paper›PMID 30449657›Full record

ArticleNeuron2018

Mutations in MAST1 Cause Mega-Corpus-Callosum Syndrome with Cerebellar Hypoplasia and Cortical Malformations.

Ratna Tripathy, Ines Leca, Tessa van Dijk, Janneke Weiss, Bregje W van Bon, Maria Christina Sergaki, Thomas Gstrein, Martin Breuss, Guoling Tian, Nadia Bahi-Buisson and 31 more

Abstract read
In one paragraph

Article in Neuron, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. A complex of MAST1 and 14-3-3η regulates Tau phosphorylation in the developing cortex.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Protective Effect ofInternational journal of molecular sciences · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Pathogenic mutation hotspots in protein kinase domain structure.Protein science : a publication of the Protein Society · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Pineal anlage tumor: a case report and the literature review.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2023
    Review
  19. Article
  20. Frontiers in molecular neuroscience · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors.

Ratna TripathyResearch Institute of Molecular Pathology, Campus Vienna Biocenter 1, Vienna Biocenter (VBC), Vienna 1030, Austria.
Ines LecaResearch Institute of Molecular Pathology, Campus Vienna Biocenter 1, Vienna Biocenter (VBC), Vienna 1030, Austria.
Tessa van DijkDepartment of Clinical Genetics, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands.
Janneke WeissAmsterdam UMC, Vrije Universiteit Amsterdam, Clinical Genetics, De Boelelaan 1117, Amsterdam, the Netherlands.
Bregje W van BonDepartment of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands.
Maria Christina SergakiResearch Institute of Molecular Pathology, Campus Vienna Biocenter 1, Vienna Biocenter (VBC), Vienna 1030, Austria.
Thomas GstreinResearch Institute of Molecular Pathology, Campus Vienna Biocenter 1, Vienna Biocenter (VBC), Vienna 1030, Austria.
Martin BreussDepartment of Neurosciences, Howard Hughes Medical Institute, University of California, San Diego, La Jolla, CA 92093, USA.
Guoling TianDepartment of Biochemistry & Molecular Pharmacology, NYU Langone Medical Center, New York, NY 10016, USA.
Nadia Bahi-BuissonUniversité Paris Descartes, Institut Cochin Hôpital Cochin, 75014 Paris, France.
Alexander R PaciorkowskiDepartment of Neurology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Alistair T PagnamentaNIHR Oxford Biomedical Research Centre, Oxford, UK, Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
Andrea Wenninger-WeinzierlResearch Institute of Molecular Pathology, Campus Vienna Biocenter 1, Vienna Biocenter (VBC), Vienna 1030, Austria.
Maria Fernanda Martinez-RezaResearch Institute of Molecular Pathology, Campus Vienna Biocenter 1, Vienna Biocenter (VBC), Vienna 1030, Austria.
Lukas LandlerResearch Institute of Molecular Pathology, Campus Vienna Biocenter 1, Vienna Biocenter (VBC), Vienna 1030, Austria.
Stefano LiseNIHR Oxford Biomedical Research Centre, Oxford, UK, Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
Jenny C TaylorNIHR Oxford Biomedical Research Centre, Oxford, UK, Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
Gaetano TerroneDepartment of Translational Medical Sciences, Section of Pediatrics, Federico II University, 80131 Naples, Italy.
Giuseppina VitielloDepartment of Translational Medical Sciences, Section of Pediatrics, Federico II University, 80131 Naples, Italy.
Ennio Del GiudiceDepartment of Translational Medical Sciences, Section of Pediatrics, Federico II University, 80131 Naples, Italy.
Nicola Brunetti-PierriDepartment of Translational Medical Sciences, Section of Pediatrics, Federico II University, 80131 Naples, Italy; Telethon Institute of Genetics and Medicine, 80078 Pozzuoli, Naples, Italy.
Alessandra D'AmicoDepartment of Advanced Medical Sciences, University of Naples Federico II, 80131 Naples, Italy.
Alexandre ReymondCenter for Integrative Genomics, University of Lausanne, 1015 Lausanne, Switzerland.
Norine VoisinCenter for Integrative Genomics, University of Lausanne, 1015 Lausanne, Switzerland.
Jonathan A BernsteinStanford School of Medicine, Stanford, CA 94305, USA.
Ellyn FarrellyStanford Children's Health, Palo Alto, CA 94304, USA.
Usha KiniDepartment of Clinical Genetics, Oxford Regional Genetics Service, Churchill Hospital, Oxford OX3 7LJ, UK.
Thomas A LeonardCenter for Medical Biochemistry, Medical University of Vienna, Max F. Perutz Laboratories, Vienna Biocenter (VBC), Campus Vienna Biocenter 5, 1030 Vienna, Austria.
Stéphanie ValenceCentre de référence des Malformations et Maladies Congénitales du Cervelet et Département de Génétique et Embryologie Médicale, APHP, Hôpital Trousseau, 75012 Paris, France.
Lydie BurglenCentre de référence des Malformations et Maladies Congénitales du Cervelet et Département de Génétique et Embryologie Médicale, APHP, Hôpital Trousseau, 75012 Paris, France.
Linlea ArmstrongProvincial Medical Genetics Programme, BCWH and Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada.
Susan M HiattHudsonAlpha Institute for Biotechnology, Huntsville, AL 35806, USA.
Gregory M CooperHudsonAlpha Institute for Biotechnology, Huntsville, AL 35806, USA.
Kimberly A AldingerSeattle Children's Research Institute, Center for Integrative Brain Research, Seattle, WA 98101, USA.
William B DobynsSeattle Children's Research Institute, Center for Integrative Brain Research, Seattle, WA 98101, USA.
Ghayda MirzaaSeattle Children's Research Institute, Center for Integrative Brain Research, Seattle, WA 98101, USA.
Tyler Mark PiersonDepartments of Pediatrics and Neurology & the Board of Governors Regenerative Medicine, Institute Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.
Frank BaasDepartment of Clinical Genetics, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands.
Jamel ChellyService de Diagnostic Génétique, Hôpital Civil de Strasbourg, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg, France.
Nicholas J CowanDepartment of Biochemistry & Molecular Pharmacology, NYU Langone Medical Center, New York, NY 10016, USA.
David Anthony KeaysResearch Institute of Molecular Pathology, Campus Vienna Biocenter 1, Vienna Biocenter (VBC), Vienna 1030, Austria. Electronic address: keays@imp.ac.at.

Funding

South-seq: DNA sequencing for newborn nurseries in the SouthU01HG007301 · NHGRI · HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI BARSH, GREGORY STEFAN, COOPER, GREGORY MICHAEL · 2017 to 2021
$11.9M
De novo copy number variation and gene discovery in human brain malformationsR01NS058721 · NINDS · UNIVERSITY OF CHICAGO · PI ARGILLI, EMANUELA · 2008 to 2025
$10.9M
Megalencephaly and segmental brain overgrowth in humansR01NS092772 · NINDS · SEATTLE CHILDREN'S HOSPITAL · PI MILLEN, KATHLEEN JOYCE · 2015 to 2019
$3.3M
Tubulin Mutations in Neuronal Migration DisordersR01GM097376 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COWAN, NICHOLAS · 2012 to 2016
$2.4M
Genes and pathways underlying brain overgrowth and focal cortical malformationsK08NS092898 · NINDS · SEATTLE CHILDREN'S HOSPITAL · PI MIRZAA, GHAYDA · 2015 to 2019
$930k
Austrian Science Fund FWF I 2681Austrian Science Fund FWF P 28135Austrian Science Fund FWF W 1261NHGRI NIH HHS U01 HG007301NIGMS NIH HHS R01 GM097376NINDS NIH HHS K08 NS092898NINDS NIH HHS R01 NS058721NINDS NIH HHS R01 NS092772
6 · The paper itself

Abstract

Corpus callosum malformations are associated with a broad range of neurodevelopmental diseases. We report that de novo mutations in MAST1 cause mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations (MCC-CH-CM) in the absence of megalencephaly. We show that MAST1 is a microtubule-associated protein that is predominantly expressed in post-mitotic neurons and is present in both dendritic and axonal compartments. We further show that Mast1 null animals are phenotypically normal, whereas the deletion of a single amino acid (L278del) recapitulates the distinct neurological phenotype observed in patients. In animals harboring Mast1 microdeletions, we find that the PI3K/AKT3/mTOR pathway is unperturbed, whereas Mast2 and Mast3 levels are diminished, indicative of a dominant-negative mode of action. Finally, we report that de novo MAST1 substitutions are present in patients with autism and microcephaly, raising the prospect that mutations in this gene give rise to a spectrum of neurodevelopmental diseases.

Indexed as

Agenesis of Corpus CallosumAnimalsAnimals, NewbornApoptosisBrainCells, CulturedCerebellumChildDevelopmental DisabilitiesDisease Models, AnimalEmbryo, MammalianFemaleGene Expression Regulation, DevelopmentalHumansMaleMalformations of Cortical DevelopmentMicrotubule-Associated ProteinsNerve Tissue ProteinsPAX6 Transcription Factorcerebellar hypoplasiacorpus callosumMAST1microdeletionmicrotubules

Identifiers

PMID30449657
PMCPMC6436622

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.